Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A study of AEOL 10150 for the treatment of Idiopathic Pulmonary Fibrosis (IPF)

Next Previous
Trial Profile

A study of AEOL 10150 for the treatment of Idiopathic Pulmonary Fibrosis (IPF)

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 27 Dec 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs AEOL 10150 (Primary)
  • Indications Idiopathic pulmonary fibrosis
  • Focus Adverse reactions

    • Most Recent Events

    • 21 Dec 2016 According to an Aeolus Pharmaceuticals media release, the U.S. Food & Drug Administration received clearance to initiate phase I studies with AEOL 10150 in healthy normal volunteers.
    • 15 Aug 2016 According to Aeolus Pharmaceuticals media release, planned initiation date changed from 1 Jul 2016 to 1 Jul 2017.
    • 15 Aug 2016 According to Aeolus Pharmaceuticals media release, company is preparing for IND submissions to the FDA and initiating clinical study over the next two quarters.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top